Results 131 to 140 of about 3,987 (159)

Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma

Biomedicine and Pharmacotherapy, 2020
Giovanna Elisiana Carpagnano, Alessandro Vatrella, Girolamo Pelaia   +2 more
exaly  

Asthma exacerbations on benralizumab are largely non‐eosinophilic

Allergy: European Journal of Allergy and Clinical Immunology, 2021
Chynna Huang, Sophie Poznanski, Parameswaran Nair   +2 more
exaly  

Benralizumab

Drugs of the Future, 2014
openaire   +1 more source

Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years

Journal of Allergy and Clinical Immunology: in Practice, 2021
Geoffrey Chupp, Arnaud Bourdin, Borja G Cosio   +2 more
exaly  

Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis

Respiratory Medicine, 2020
Giovanni Rolla, Luisa Brussino, Marco Caminati   +2 more
exaly  

Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study

Journal of Clinical Medicine, 2023
Nicola Scichilone, Alessandro Vatrella, Girolamo Pelaia   +2 more
exaly  

Promising Effects of Benralizumab on Chronic Eosinophilic Pneumonia

Internal Medicine, 2020
Akimasa Sekine, Naoto Aiko, Tomohisa Baba   +2 more
exaly  

Eosinophils, the IL-5/IL-5Rα axis, and the biologic effects of benralizumab in severe asthma

Respiratory Medicine, 2019
Enrico Maggi, Andrea Matucci, Alessandra Vultaggio   +2 more
exaly  

Reductions in eosinophil biomarkers by benralizumab in patients with asthma

Respiratory Medicine, 2016
Paul Newbold, Gautam Damera
exaly  

Benralizumab/omalizumab

Reactions Weekly, 2022
openaire   +2 more sources